Blog
RSS FeedPosted by Michael Wonder on 17 Jan 2022
TGA recognises the Gamaleya Institute vaccine (Sputnik V, Russian Federation) for international travel to Australia
17 January 2022 - Today, the TGA determined that an additional COVID-19 vaccine, the two dose course of the Gamaleya ...
Posted by Michael Wonder on 13 Jul 2021
European efforts to assess Russia’s Sputnik V vaccine stymied by data gaps
13 July 2021 - The developers of Russia’s Sputnik V coronavirus vaccine have repeatedly failed to provide data that regulators ...
Posted by Michael Wonder on 22 Apr 2021
WHO and EMA to inspect Sputnik V manufacturing in May
22 April 2021 - Technical experts from the World Health Organization are due to start the next round of their ...
Posted by Michael Wonder on 22 Mar 2021
EU has 'absolutely no need' of Russia's Sputnik V vaccine, commissioner says
21 March 2021 - The European Union does not need Russia's Sputnik V vaccine for Covid-19 and can achieve immunity ...
Posted by Michael Wonder on 20 Feb 2021
Confusion over Russia's EU vaccine approval bid could be result of misdirected application
20 February 2021 - Russia’s submission of its Sputnik V vaccine for approval by the European Union’s medicines regulator appears ...
Posted by Michael Wonder on 10 Feb 2021
Clarification on Sputnik V vaccine in the EU approval process
10 February 2021 - The EMA has to date not received an application for a rolling review or a marketing ...
Posted by Michael Wonder on 25 Nov 2020
Russia looks to undercut rivals with cut-price COVID-19 vaccine
24 November 2020 - Phase 3 trials showed the jab was 91.4% effective in protecting people from COVID-19. ...
Posted by Michael Wonder on 12 Aug 2020
US hoses down Russian vaccine, says it will have millions of doses ready year's end
12 August 2020 - US Health Secretary Alex Azar has criticised a COVID-19 vaccine being promoted by Russian President Vladimir ...
Posted by Michael Wonder on 11 Aug 2020
Russia's approval of coronavirus vaccine greeted with some alarm
12 August 2020 - Russia has become the first country to approve a coronavirus vaccine for use in tens of ...
Posted by Michael Wonder on 14 May 2020
Russia says search for a coronavirus treatment should not be a medical ‘arms race’
14 May 2020 - Russia’s sovereign wealth fund has been funding Russian development and production of the drug favipiravir, an anti-influenza ...
Posted by Michael Wonder on 19 Sep 2019
First biosimilar of dornase alfa inhalation solution for CF approved in Russia, companies announce
19 September 2019 - A biosimilar of dornase alfa inhalation solution, with the same therapeutic activity as Pulmozyme, its reference ...
Posted by Michael Wonder on 30 Aug 2019
Russia approves Spinraza to treat all SMA patients
29 August 2019 - Russia has become the first of the 15 former Soviet republics to approve Biogen’s Spinraza (nusinersen) ...